$AME

Ametek earnings beat by $0.10, revenue topped estimates

Ametek (NYSE: AME) reported Q3 EPS of $2.21, beating estimates by $0.10, with revenue at $2.22B, exceeding expectations. The stock is down 4.63% over 3 months but up 22.14% over 12 months. InvestingPro rates its financial health as 'good performance'.

Original reporting
Published Nov 3, 2026, 12:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 12:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AME
Bullish
medium confidence
Mentioned
$AME
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AMEBullishMed
01

Why it matters

Traders can use the beat versus consensus to reassess near-term expectations, but without guidance or segment/margin data the decision edge is limited to expectation-setting rather than forward forecasting.

02

Market read

Earnings beat on both EPS and revenue is a direct catalyst for AME positioning around the earnings window.

03

What to watch

The piece does not include management guidance, segment performance, or cash flow, which are often the real drivers of post-earnings moves beyond the headline beat.

Relevance 8/10Novelty 8/10Timing: reported Q3 results, with stock close referenced

Background

The article is an Investing.com earnings write-up for Ametek’s third quarter results versus analyst consensus.

Company-level read

Ticker impact

$AMEBullishMedium confidence
Context

Ametek reported Q3 EPS of $2.21, beating the $2.11 estimate, and revenue of $2.22B versus $2.12B consensus.

Expected impact

Likely upward bias as the market digests the beat versus consensus, with follow-through depending on any guidance not included here.

Evidence & confidence

The article contains the company’s own quarterly print versus consensus (EPS and revenue), which typically drives same-day and next-session repricing; however, no forward guidance or margin detail is provided to refine magnitude.

Market effects

Signals demand and pricing resilience for industrial instrumentation/electromechanical supply chains, but no sector-wide read-through is provided.

Primarily single-name impact; no macro or regional linkage beyond general risk sentiment.

Limited global relevance since the article is company-specific and lacks international segment detail.

Counterpoint

A beat can still disappoint if margins, backlog, or forward guidance weaken; the article omits those details.

Key entities

  • Ametek

    Reported Q3 EPS and revenue versus consensus estimates.

Related articles

$AMEHighAI 9/10

AMETEK Posts Record Q3 Sales and Adjusted EPS, Raises 2026 Guidance

AMETEK reported Q3 2026 sales of $2.22B, up 17% YoY, and adjusted EPS of $2.21. GAAP EPS was $1.85, with net income at $426.3M. The company raised its full-year adjusted EPS outlook to $8.53–$8.57. Growth was driven by organic sales, acquisitions, and strong demand across its businesses. AMETEK also completed the acquisition of Indicor Instrumentation.

$AMEHighAI 9/10

AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Nov 3, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the third quarter ended September 30, 2026. AMETEK’s third quarter 2026 sales were a record

$AMEMedAI 8/10

AMETEK Boosts FY26 Outlook - Update

AMETEK (AME) reported Q3 results and raised its FY26 outlook. Q4 adjusted earnings are expected to be $2.26-$2.30 per share with net sales growth in the low 20% range. FY26 adjusted earnings are now projected to be $8.53-$8.57 per share with mid-teen percentage net sales growth, up from previous guidance of $8.20-$8.30 per share. AME stock is up 0.86% in pre-market trading.

$AMEMedAI 9/10

AMETEK’s (NYSE:AME) Q3 2026 sales beat estimates

AMETEK reported Q3 2026 revenue of $2.22 billion, exceeding estimates by 2.9% and growing 17.3% year-on-year. Adjusted EPS was $2.21, beating estimates by 4.8%. Management raised full-year adjusted EPS guidance to $8.55 at the midpoint, a 3.6% increase. Operating margin remained steady at 26.3%, while free cash flow margin improved to 23.8% from 22.2% year-on-year.

$AMEMedAI 9/10

Ametek: Q3 Earnings Snapshot

Ametek Inc. (AME) reported Q3 net income of $426.3M, or $1.85 per share, beating estimates. Revenue was $2.22B, also surpassing forecasts. The company projects Q4 EPS of $2.26-$2.30 and full-year EPS of $8.53-$8.57. Shares are up 18% YTD and 20% over 12 months.